Skip to main content
Lippincott Open Access logoLink to Lippincott Open Access
. 2018 Jun 27;114(4):696. doi: 10.1038/s41395-018-0401-4

Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium

Neeraj Narula, Farhad Peerani, Joseph Meserve, Gursimran Kochhar, Khadija Chaudrey, Justin Hartke, Prianka Chilukuri, Jenna Koliani-Pace, Adam Winters, Leah Katta, Eugenia Shmidt, Robert Hirten, David Faleck, Malav P Parikh, Diana Whitehead, Brigid S Boland, Siddharth Singh, Sashidhar Varma Sagi, Monika Fischer, Shannon Chang, Morris Barocas, Michelle Luo, Karen Lasch, Matthew Bohm, Dana Lukin, Keith Sultan, Arun Swaminath, David Hudesman, Nitin Gupta, Bo Shen, Sunanda Kane, Edward V Loftus, Corey A Siegel, Bruce E Sands, Jean-Frederic Colombel, William J Sandborn, Parambir S Dulai
PMCID: PMC6455086  PMID: 30390030

Correction to: The American Journal of Gastroenterology; https://doi.org/10.1038/s41395-018-0162-0; published online June 27, 2018

This Article was originally published under Nature Research’s License to Publish, but has now been made available under a CC BY-NC-ND license. The PDF and HTML versions of the Article have been modified accordingly.


Articles from The American Journal of Gastroenterology are provided here courtesy of Wolters Kluwer Health

RESOURCES